Source: StockMonkeys.com via Flickr.It’s been a truly transformative year for Gilead Sciences and its shareholders. Even taking into consideration the latest swoon in Gilead’s share price tied to the approval of AbbVie ‘s Viekira Pak and its subsequent multi-year agreement with Express Scripts , Gilead shares are up 25% for the year, essentially doubling the return of the S&P 500 […]
It was generally a good year for biotechnology stocks, but the sector remains a risky one. Below are 20 biotechnology companies that lost more than 70% of their value in 2014. (Click here for a list of the best performers.)There aren’t many lessons here. Tolstoy said that happy families are all alike, and but every unhappy family is unhappy in […]
Nanosonics chief Michael Kavanagh wants to build Australia’s next medical device success story, replicating the success of his old employer, bionic ear maker Cochlear. Photo: Louie DouvisAfter a disappointing year for local biotechnology stocks, in which a number of high profile companies faltered on the back of poor clinical results or internal blunders, investors are scouring the sector for the […]
View gallery.After last week’s hammering of biotech stocks, many have not been able to recover to hit new highs with the overall market.Previous high flyers such as Agios Pharmaceuticals Inc (NASDAQ: AGIO) and Receptos Inc (NASDAQ: RCPT) have bounced, but still lag the Nasdaq.Others, such as Bluebird Bio Inc (NASDAQ: BLUE) have actually managed to eek out new highs.Unfortunately, there are the […]
This healthcare edition of Industry Focus takes a look at three biotech stocks and why each company is positioned for a great performance in the coming year.If your portfolio could use some exposure to healthcare and biotechs, join the Fool’s Michael Douglass and Todd Campbell, along with special guest Kristine Harjes, to learn more about three promising stocks in the […]
See original article:
Biotech Stocks Make Big Moves In Final Days Of 2014
[…]
View gallery.The graphs below were produced by Capital Market Labs.A critical factor in assessing pharmaceutical and biotech companies is the quality of their drug pipelines. This is especially true as investors begin to look at the smaller companies in the space; the smaller the company, the more an investment is simply a bet on that particular pipeline.So, let’s take a look […]
Biotechnology’s mind-numbing share price volatility means that only the most risk-tolerant investors should consider owning them — but for investors with a penchant for risk and a stomach tough enough to handle the inevitable pops and drops, there may be opportunities to discover emerging biotech companies with promising pipelines that could send their shares significantly higher in 2015. Ophthotech Corporation […]
View gallery.This week brings to close yet another year of gains for the stock market, the sixth straight year in this bull run.The benchmark S&P 500 started off 2014 at 1848 and as of Friday the index sat at 2088.Some of the top industries of the year include airlines, semiconductors, hospitals, aluminum, Internet service providers and residential REITs.Another industry cracking this […]
